Morgan Stanley Nexalin Technology, Inc. Transaction History

Morgan Stanley

  • $1.36 Trillion
  • Q1 2025

A detailed history of Morgan Stanley transactions in Nexalin Technology, Inc. stock. As of the latest transaction made, Morgan Stanley holds 500 shares of NXL stock, worth $580. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500
Holding current value
$580
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$1.91 - $3.72 $955 - $1,860
500 New
500 $0
Q2 2024

May 14, 2025
BUY
$0.61 - $2.96 $36,481 - $177,022
59,805 New
59,805 $101,000
Q2 2024

Aug 14, 2024
BUY
$0.61 - $2.96 $36,481 - $177,022
59,805 New
59,805 $101,000
Q1 2023

May 15, 2023
SELL
$0.75 - $1.22 $588 - $957
-785 Reduced 38.41%
1,259 $1,000
Q4 2022

Feb 14, 2023
BUY
$0.74 - $2.39 $1,512 - $4,885
2,044 New
2,044 $1,000

Others Institutions Holding NXL

# of Institutions
19
Shares Held
452K
Call Options Held
0
Put Options Held
0
View Full List

About Nexalin Technology, Inc.

NXL Quotes by TradingView
  • Ticker NXL
  • Exchange
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 7,279,960
  • Market Cap $8.44M
More about NXL
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email